Emergent BioSolutions (NYSE:EBS – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report issued on Tuesday. EBS has been the subject of several other ...
Rodman & Renshaw initiated coverage of Adial Pharmaceuticals (ADIL) with a Buy rating and $8 price target The firm believes Adial has the potential to outperform over the next 12 months, saying its ...
Following reports that his 1999 teen cult classic Idle Hands is being reimagined by screenwriting duo Finn Wolfhard and Billy Bryk, with Jason Reitman producing, Sawa shared his son’s reaction to the ...